Esophagopleural fistula treated with muscular ventricular septal defect occluder

To the Editor, Esophageal-pleural fistulas are a rare complication of thoracic surgery. They may occur as the direct result of trauma during surgery or use of a transesophageal device. The management of esophageal-pleural fistulas can be difficult, and they rarely heal spontaneously. Conservative ma...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rafael Vera-Urquiza, José M. Esteban López-Jamar, Luis Nombela-Franco, Manuel Vázquez Romero, Carolina Espejo, Pilar Jiménez-Quevedo
Formato: article
Lenguaje:EN
ES
Publicado: Permanyer 2021
Materias:
R
Acceso en línea:https://doaj.org/article/9321c77e708e4c4ebb0f1a7a84d652ce
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9321c77e708e4c4ebb0f1a7a84d652ce
record_format dspace
spelling oai:doaj.org-article:9321c77e708e4c4ebb0f1a7a84d652ce2021-11-16T10:14:17ZEsophagopleural fistula treated with muscular ventricular septal defect occluder10.24875/RECICE.M200001752604-7322https://doaj.org/article/9321c77e708e4c4ebb0f1a7a84d652ce2021-11-01T00:00:00Zhttps://recintervcardiol.org/en/index.php?option=com_content&view=article&id=512https://doaj.org/toc/2604-7322To the Editor, Esophageal-pleural fistulas are a rare complication of thoracic surgery. They may occur as the direct result of trauma during surgery or use of a transesophageal device. The management of esophageal-pleural fistulas can be difficult, and they rarely heal spontaneously. Conservative management of esophageal-pleural fistulas are associated with high mortality rates. The traditional treatment of symptomatic patients is surgery. However, this type of surgery has high morbidity and mortality rates; for this reason, many patients are not eligible for surgery. The endoscopic treatment options to repair esophageal fistulas include the injection of glue, covered stents, and endoscopic suture or clipping. After treatment failure, we considered the use of an emerging therapeutic technique as an alternative treatment. In this context, we present a case of a iatrogenic esophageal fistula treated with an Amplazer device. This is the case of a 72-year-old woman, former smoker with a past medical history of hypertension, chronic atrial fibrillation, and rheumatic mixed mitral valve disease who was admitted due to acute coronary syndrome. A thrombotic occlusion...Rafael Vera-UrquizaJosé M. Esteban López-JamarLuis Nombela-FrancoManuel Vázquez RomeroCarolina EspejoPilar Jiménez-QuevedoPermanyerarticleMedicineRENESREC: Interventional Cardiology (English Ed.), Vol 3, Iss 4, Pp 318-320 (2021)
institution DOAJ
collection DOAJ
language EN
ES
topic Medicine
R
spellingShingle Medicine
R
Rafael Vera-Urquiza
José M. Esteban López-Jamar
Luis Nombela-Franco
Manuel Vázquez Romero
Carolina Espejo
Pilar Jiménez-Quevedo
Esophagopleural fistula treated with muscular ventricular septal defect occluder
description To the Editor, Esophageal-pleural fistulas are a rare complication of thoracic surgery. They may occur as the direct result of trauma during surgery or use of a transesophageal device. The management of esophageal-pleural fistulas can be difficult, and they rarely heal spontaneously. Conservative management of esophageal-pleural fistulas are associated with high mortality rates. The traditional treatment of symptomatic patients is surgery. However, this type of surgery has high morbidity and mortality rates; for this reason, many patients are not eligible for surgery. The endoscopic treatment options to repair esophageal fistulas include the injection of glue, covered stents, and endoscopic suture or clipping. After treatment failure, we considered the use of an emerging therapeutic technique as an alternative treatment. In this context, we present a case of a iatrogenic esophageal fistula treated with an Amplazer device. This is the case of a 72-year-old woman, former smoker with a past medical history of hypertension, chronic atrial fibrillation, and rheumatic mixed mitral valve disease who was admitted due to acute coronary syndrome. A thrombotic occlusion...
format article
author Rafael Vera-Urquiza
José M. Esteban López-Jamar
Luis Nombela-Franco
Manuel Vázquez Romero
Carolina Espejo
Pilar Jiménez-Quevedo
author_facet Rafael Vera-Urquiza
José M. Esteban López-Jamar
Luis Nombela-Franco
Manuel Vázquez Romero
Carolina Espejo
Pilar Jiménez-Quevedo
author_sort Rafael Vera-Urquiza
title Esophagopleural fistula treated with muscular ventricular septal defect occluder
title_short Esophagopleural fistula treated with muscular ventricular septal defect occluder
title_full Esophagopleural fistula treated with muscular ventricular septal defect occluder
title_fullStr Esophagopleural fistula treated with muscular ventricular septal defect occluder
title_full_unstemmed Esophagopleural fistula treated with muscular ventricular septal defect occluder
title_sort esophagopleural fistula treated with muscular ventricular septal defect occluder
publisher Permanyer
publishDate 2021
url https://doaj.org/article/9321c77e708e4c4ebb0f1a7a84d652ce
work_keys_str_mv AT rafaelveraurquiza esophagopleuralfistulatreatedwithmuscularventricularseptaldefectoccluder
AT josemestebanlopezjamar esophagopleuralfistulatreatedwithmuscularventricularseptaldefectoccluder
AT luisnombelafranco esophagopleuralfistulatreatedwithmuscularventricularseptaldefectoccluder
AT manuelvazquezromero esophagopleuralfistulatreatedwithmuscularventricularseptaldefectoccluder
AT carolinaespejo esophagopleuralfistulatreatedwithmuscularventricularseptaldefectoccluder
AT pilarjimenezquevedo esophagopleuralfistulatreatedwithmuscularventricularseptaldefectoccluder
_version_ 1718426562696577024